| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 31 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 29 |
| 2 | TACROLIMUS OINTMENT 0.1% | 29 |
| 3 | MYCOPHENOLATE MOFETIL | 28 |
| 4 | PREDNISOLONE | 27 |
| 5 | PREDNISOLONE ORAL | 27 |
| 6 | PREDNISOLONE ORAL SOLUTION | 27 |
| 7 | PREDNISONE | 21 |
| 8 | METHYLPREDNISOLONE | 17 |
| 9 | ALEMTUZUMAB | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RIFABUTIN | 6 | 0.0022 |
| 1 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 2 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 3 | CEFIXIME | 3 | 0.0010 |
| 4 | INTERFERON GAMMA-1B | 1 | 0.0007 |
| 5 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 6 | CLOFAZIMINE | 4 | 0.0006 |
| 7 | ANIDULAFUNGIN | 1 | 0.0006 |
| 8 | ALEMTUZUMAB | 11 | 0.0006 |
| 9 | SIROLIMUS | 7 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antimycobacterial [EPC] | 6 | 0.0017 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Interferon gamma [EPC] | 1 | 0.0007 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 11 | 0.0006 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 6 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Sulfone [EPC] | 3 | 0.0003 |
| 8 | Antimycobacterial [EPC] | 5 | 0.0002 |
| 9 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |